We provide a basis for the future understanding of inflammatory signaling in GC development and suggested that miR-26b-5p, PDE4B, and CDK8 may be promising biomarkers for clinical therapies for inflammation-mediated GC. The gene discussed is CDK8; the disease is gastric cancer.